Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]
Conditions
Interventions
None listed
Sponsors
Dr Gaurav Narula Professor Medical Oncology Pediatrics Unit
Eligibility
Inclusion criteria
Inclusion criteria: a) Patients of either gender and age between 1-15 years treated with one cycle in induction phase (On going or completed consolidation and maintenance phase also included). b) Parent/Legally Acceptable Representative (LAR) of the patient willing to give voluntary informed consent. c) Patient above 8 years willing to give voluntary assent
Exclusion criteria
Exclusion criteria: 1. Any other medical condition, which in the opinion of the investigator precludes the inclusion of the participant. 2. Critically ill patients of Acute lymphoblastic Leukaemia admitted to emergency department 3. Newly diagnosed and treatment naïve patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drugs prescribed in treatment of Acute Lymphoblastic Leukaemia patientsTimepoint: 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The type, causality, severity and preventability of ADRs in Acute Lymphoblastic Leukaemia. Timepoint: 18 months;To evaluate the Cost of Illness in Acute Lymphoblastic Leukaemia. Timepoint: 18 months | — |
Countries
India
Contacts
Public ContactDr Ankita Kulkarni
Seth GSMC & KEMH Mumbai
Outcome results
None listed